Catalyst Wire Dossier Catalyst Wire Dossier

ibrefxngerp

ibrexafungerp · Scynexis, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ibrefxngerp, covering 2019-07-12 to 2019-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis [Phase 2]

See pricing